$AFCG

TANNENBAUM LEONARD M purchased $204K of AFCG

TANNENBAUM LEONARD M purchased 60,000 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.40 ($3.40–$3.41, $0.20M total) across 2 trades over 2026-08-24 to 2026-08-25.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Aug 26, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AFCG
Bullish
medium confidence
Mentioned
$AFCG
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGBullishLow
01

Why it matters

Traders may treat the buy as a mild positive signal, but without accompanying operational news, it is more useful for monitoring than for making a high-conviction trade.

02

Market read

A reported insider open-market buy in AFCG may slightly improve sentiment, but the disclosure alone is unlikely to be a major catalyst.

03

What to watch

The article does not provide context on prior insider activity, overall float, or whether the purchases were part of a broader accumulation pattern.

Relevance 5/10Novelty 5/10Timing: Filed on 2026-08-26, covering purchases dated 2026-08-24 to 2026-08-25.

Background

This is an SEC Form 4 insider transaction by a director and 10% owner, reporting open-market purchases without a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AFCGBullishMedium confidence
Context

Director and 10% owner Tannenbaum Leonard M bought 60,000 shares of Advanced Flower Capital at about $3.405/share for ~$204.3K, per Form 4.

Expected impact

Near-term impact likely limited; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 shows open-market purchases with no 10b5-1 plan, which can be read as conviction, but the transaction value (~$204K) is small relative to typical market-moving thresholds.

Market effects

Minimal, as this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or tax/portfolio-driven, and the modest ~$204K size may not reflect a strong forward view.

Key entities

  • Advanced Flower Capital Inc.

    Subject of the Form 4 insider purchase disclosure.

  • Tannenbaum Leonard M

    Director and 10% owner who purchased shares in two trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.